• Contact
  • EPAD Academy
Top Bar Menu
TwitterFacebookYouTube
Search...
EPADEPAD
EPAD
European Prevention of Alzheimer's Dementia Consortium
  • Home
  • About
    • Welcome to EPAD
    • Project Objectives
    • Project Structure
    • EPAD Partners
    • Coordination & Management
    • EPAD Q&A
  • Our research
    • Participation in EPAD
      • Participation in EPAD Cohort
      • EPAD Study Visits
      • Trial Locations
      • Participation FAQs
    • The Participant’s Experience
      • The Research Participant Panel
      • EPAD Stories
    • The EPAD platform
      • The EPAD Platform
      • EPAD Benefits
      • Clinical Candidate Selection
      • EPAD FAQs
      • Research Resources
  • Open Access Data
    • Overview
    • Access
    • Data
    • MRI Images
  • Sample Access
  • News & Publications
    • Latest News
    • Newsletters
    • Publications
    • Videos
Menu back  

EPAD Scotland inaugural meeting sees progress and participants at heart of agenda

2018-08-29News

On 29 August, EPAD’s Scottish team were lucky enough to visit the stunning University of Aberdeen campus for the inaugural EPAD Scotland conference.

Held in the historic heart of the University, almost 80 delegates including participants, site staff and the wider Scottish EPAD team were treated to an uplifting and informative day of talks, as well as some unseasonal sunshine which saw the breakout sessions take place outside on the lawn!

After an energetic coffee session, Professor Craig Ritchie opened the day with introductions; it was great to hear everyone describe their role in the project. This was quickly followed an overview of EPAD and its place in the future of Alzheimer’s dementia research. Craig discussed why bringing the intervention timeline forward is so important for future patients and how EPAD’s unique public-private partnership is working towards this goal.

“Where we start will not be where we end in EPAD, we are learning a lot.” Professor Craig Ritchie

Professor Ritchie also announced that we now have the first tranche of data from our research participants and are taking the responsibility we have to get the best science out it, seriously.

Our research participants were firmly at the heart of the event, and next up saw Brian and Eileen, two of our participants panel members, take to the floor for a discussion. Both are hugely enthusiastic about the project and their part in it, and it was a joy to hear their insights. Brian and Eileen also had the chance to watch the video interviews they participated in at the 2018 General Assembly. It was an emotional moment for them and everyone in the room. You can watch the new research participant interview videos on EPAD’s YouTube channel.

A quick and lively coffee break and we were back in the room to hear from Craig Ritchie on the Longitudinal Cohort Study (LCS) taskforce. This included the impressive stats on our recruitment progress and the news that Scotland is doing very well in the recruitment stakes – we are a competitive bunch!

It was interesting to hear from NHS Grampian’s Catriona Murray, an Advanced Nurse Practitioner who manages the lumbar puncture procedure required of research participants. An obstacle for many potential participants, Catriona explained how well trained and professional her team are, providing reassurance to many of the participants present. She also discussed why cerebrospinal fluid is important for EPAD’s biomarkers analysis and the different positions that participants can take to make collection easier, along with some post-procedure recovery tips.

Sarah Gregory, Study Coordinator at EPAD’s lead site situated at the University of Edinburgh’s Centre for Dementia Prevention then introduced what they have learned about research recruitment and retention thus far using the Generation Scotland cohort and the PREVENT Dementia study. The team is now gearing up towards recruiting from the newly launched Scottish Brain Health Registry and believe that it will be of benefit to EPAD’s recruitment strategy in Scotland.

“The next 12 months for our site will be spent focussing on getting ready for the Proof of Concept trials and expanding the success of the participant panel across Scotland.” Sarah Gregory

Sarah also outlined how PrePAD Velocity is not only boosting recruitment, but further enriching the LCS with prodromal Alzheimer’s disease research participants, thus ensuring that the LCS can serve as a successful readiness cohort for the first PoC appendix.

NHS’s Greater Glasgow & Clyde’s Shona McKay then delivered a fantastic presentation on hard to reach groups. With EPAD recruiting almost exclusively from socio-economic groups at the top end of the scale in Glasgow, Shona asked what we should be doing to reach out to and engage those groups which are less easy to communicate with in order to drive an uptake in participation in deprived areas where elderly people are at an increased risk of developing dementia.

“EPAD’s longitudinal design lends itself well to addressing and engaging seldom heard groups across socio-economic groups.”  Shona McKay

This presentation sparked some interesting discussions over lunch, which we were lucky enough to be able to eat outside. It was also the perfect weather to conduct an outdoor interview with Craig Ritchie, project co-coordinator and native Aberdonian, which you can watch here.

The afternoon session focused around workshops, giving everyone present an opportunity to give their thoughts on how EPAD’s recruitment, retention and engagement strategies are working, and give ideas and feedback for the team to take forward. These breakout sessions were hugely valuable and the outputs from these have been collated and shared with the relevant work package teams to progress.

Dr Kristy Draper picked the afternoon sessions back up with her update on the proof of concept (Poc) trials. With the PoC platform now launched and attracting a great deal of interest from the pharmaceutical sector, it was encouraging to see the how the consortium’s work is coming together to support drug development and provide trial-ready cohorts to proof-of-concept trials.

The meeting was brought to a close by Professor Alison Murray, the Roland Sutton Chair of Radiology at the University of Aberdeen, who leads research into cognitive resilience within the Generation Scotland subsample of Aberdeen Children of the 1950s. Utilising cognitive tests routinely used in Aberdeen schools in the 1950s and 1960s as a starting point, Professor Murray demonstrated how the effects of childhood IQ have an impact on neurological impairment in later life, with early education and mid-life occupation contributing to greater cognitive resilience.

Professor Murray’s talk was a fascinating end to an overall fascinating day. I’m pleased to say that this is just the first of what we hope will become an annual EPAD Scotland Conference. If this first conference is anything to go by, the EPAD Scotland team is set to benefit year after year.

Share this post
FacebookTwitterLinkedInGoogle+
Related posts
Analysis of multiple steroids in saliva in the EPAD study
2023-03-02
Hormone Replacement Therapy could ward off Alzheimer’s among at-risk women
2023-01-16
Associations between Mediterranean diet and cognition in the pan-European EPAD LCS
2022-12-09
Bruno Steinkraus
Interview with Dr. Bruno Steinkraus, Chief Scientific Officer at Hummingbird Diagnostics GmbH
2022-11-25
New paper defining and discussing the substantial assets of the EPAD project is out!
2022-11-23
New paper using the EPAD data for an analysis of sleep quality and efficiency
2022-11-03
Latest News
  • Analysis of multiple steroids in saliva in the EPAD study
    2023-03-02
  • Hormone Replacement Therapy could ward off Alzheimer’s among at-risk women
    2023-01-16
  • Associations between Mediterranean diet and cognition in the pan-European EPAD LCS
    2022-12-09
  • Bruno Steinkraus
    Interview with Dr. Bruno Steinkraus, Chief Scientific Officer at Hummingbird Diagnostics GmbH
    2022-11-25
  • New paper defining and discussing the substantial assets of the EPAD project is out!
    2022-11-23
View the EPAD Brochure
thumbnail of EPAD brochure
Speak to the EPAD team
thumbnail of speech bubbles
Twitter
Twitter
EPAD
EPAD
@IMI_EPAD

📢@imi_epnd has launched its Cohort Catalogue, a central, open & accessible repository for researchers to discover studies & search metadata. Currently 67 research cohorts from 17 countries across Europe including @IMI_EPAD-VUmc participants ⬇️ eurekalert.org/news-releases/… twitter.com/imi_epnd/statu…

reply retweet favorite
9:56 am · 2023-03-14
Twitter
EPAD
EPAD
@IMI_EPAD

NEW paper published in @MetabolitesMDPI using LC-MS/MS method to determine salivary steroids using @IMI_EPAD samples. Congratulations @GregorySarah @zinghomer @guider50 @scottgdenham👏 @EdMassSpecCore @IMI2_NEURONET @IHIEurope #mdpimetabolites mdpi.com/2133518

reply retweet favorite
12:55 pm · 2023-03-02
Twitter
EPAD
EPAD
@IMI_EPAD

"There is a growing consensus that individual research results that are potentially relevant should be reported to research participants” & “Our work was positively received by the EPAD partners, and formed the basis for the set-up & the conduct of the study,” said Eline Bunnik

reply retweet favorite
10:32 am · 2023-01-31
Twitter
EPAD
EPAD
@IMI_EPAD

Have a look on the @IHIEurope newsletter including a spotlight on IMI results from projects on diabetes @HypoResolve and #Alzheimer’s disease @IMI_EPAD @IMI_AMYPAD ⬇️ Read it: bit.ly/3jeaxdM twitter.com/IHIEurope/stat…

reply retweet favorite
10:30 am · 2023-01-31
Twitter
EPAD
EPAD
@IMI_EPAD

17 centres have contributed to the @IMI_AMYPAD Prognostic Study across 11 Parent Cohorts including @IMI_EPAD. Have a look on the latest AMYPAD paper published in @FrontNeurol ⬇️ twitter.com/IMI_AMYPAD/sta…

reply retweet favorite
8:19 am · 2023-01-30
Workstream Progress
Workstream 120%
Workstream 232%
Workstream 310%
Workstream 446%
Contact us

Submitclear

Recent Posts
  • Analysis of multiple steroids in saliva in the EPAD study
  • Hormone Replacement Therapy could ward off Alzheimer’s among at-risk women
  • Associations between Mediterranean diet and cognition in the pan-European EPAD LCS
  • Interview with Dr. Bruno Steinkraus, Chief Scientific Officer at Hummingbird Diagnostics GmbH
  • New paper defining and discussing the substantial assets of the EPAD project is out!
Recent Comments
  • The EPAD genomic data is now available on the Alzheimer’s Disease Workbench on The EPAD genomic data is now available on the Alzheimer’s Disease Workbench
  • ADDI celebrates one year of achievements – Neuronet on ADDI celebrates one year of achievements
  • EPAD dataset is now available on the Alzheimer’s Disease Workbench on The final EPAD dataset is now available on the Alzheimer’s Disease Workbench
  • The final EPAD dataset is now available to the entire research community on The final EPAD dataset is now available to the entire research community
  • The ERC has awarded an ERC grant to identify age-related human blood factors as a therapeutic target for Alzheimer’s disease – Neuronet on New ERC starting grant to identify age-related human blood factors as a therapeutic target for Alzheimer’s disease
Archives
  • March 2023
  • January 2023
  • December 2022
  • November 2022
  • October 2022
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • January 2022
  • November 2021
  • October 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
  • March 2021
  • February 2021
  • November 2020
  • October 2020
  • September 2020
  • July 2020
  • June 2020
  • April 2020
  • March 2020
  • February 2020
  • January 2020
  • December 2019
  • November 2019
  • October 2019
  • September 2019
  • August 2019
  • July 2019
  • June 2019
  • May 2019
  • April 2019
  • March 2019
  • February 2019
  • January 2019
  • December 2018
  • November 2018
  • October 2018
  • September 2018
  • August 2018
  • July 2018
  • June 2018
  • May 2018
  • April 2018
  • March 2018
  • February 2018
  • January 2018
  • December 2017
  • November 2017
  • October 2017
  • September 2017
  • July 2017
  • June 2017
  • May 2017
  • April 2017
  • March 2017
  • February 2017
  • January 2017
  • December 2016
  • November 2016
  • October 2016
  • September 2016
  • August 2016
  • July 2016
  • June 2016
  • May 2016
  • April 2016
  • March 2016
  • February 2016
  • January 2016
  • December 2015
  • November 2015
  • October 2015
  • September 2015
  • August 2015
  • June 2015
  • May 2015
  • April 2015
Categories
  • EPAD Academy
  • News
Meta
  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org
Copyright © 2015-2021 EPAD | Created by CMAST and Aridhia
  • Acronyms
  • Legal Notice
  • Privacy Policy
Bottom Menu

efpia-logo EU imi logo

This work has received support from the EU/EFPIA Innovative Medicines Initiative Joint Undertaking EPAD grant agreement nº 115736

This website uses cookies to improve your experience. Accept Read More
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT